CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease

Abstract

The chemokine receptor CCR2 appears to be an important contributor to accumulation of CD4(+) T lymphocytes in the ileum in small bowel Crohn's disease. Blockade of CCR2 may provide a novel therapeutic alternative.